TSHA · Taysha Gene Therapies, Inc.
$5.95
-0.04 (-0.67%)
At close · Aug 14
Market Cap
$2.09B
Shares
325.83M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding TSHA
217 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | VB | 6,851,650 | $37,684,075 | 0.00% | Long | 2025-12-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 7,513,950 | $33,587,357 | 0.00% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | BWX | 5,712,858 | $31,420,719 | 0.40% | Long | 2025-12-31 | |
| iShares Russell 2000 ETF | AAXJ | 5,592,001 | $30,756,006 | 0.04% | Long | 2025-12-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 5,638,911 | $25,205,932 | 0.34% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 4,176,103 | $24,513,725 | 0.02% | Long | 2026-05-31 | |
| iShares Russell 2000 ETF | — | 5,410,999 | $24,187,166 | 0.03% | Long | 2026-03-31 | |
| Fidelity Small Cap Index Fund | — | 2,184,341 | $13,957,939 | 0.04% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | VB | 2,397,431 | $13,185,871 | 0.02% | Long | 2025-12-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,478,922 | $11,080,781 | 0.01% | Long | 2026-03-31 | |
| iShares Russell 2000 Growth ETF | AAXJ | 1,924,755 | $10,586,153 | 0.08% | Long | 2025-12-31 | |
| Fidelity Small Cap Index Fund | FSTB | 2,135,599 | $9,631,551 | 0.03% | Long | 2026-01-31 | |
| iShares Biotechnology ETF | AAXJ | 1,654,792 | $9,101,356 | 0.11% | Long | 2025-12-31 | |
| iShares Russell 2000 Growth ETF | — | 1,793,905 | $8,018,755 | 0.07% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 1,672,180 | $7,474,645 | 0.09% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 1,147,608 | $6,736,459 | 0.02% | Long | 2026-05-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 1,134,540 | $6,659,750 | 0.04% | Long | 2026-05-31 | |
| Fidelity Growth Company K6 Fund | — | 1,098,103 | $6,445,865 | 0.02% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | — | 1,069,955 | $6,280,636 | 0.03% | Long | 2026-05-31 | |
| Fidelity Advisor Biotechnology Fund | — | 939,800 | $6,005,322 | 0.32% | Long | 2026-04-30 | |
| Select Biotechnology Portfolio | — | 940,476 | $5,520,594 | 0.10% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | FNDA | 1,057,597 | $5,013,010 | 0.03% | Long | 2025-11-30 | |
| VANGUARD RUSSELL 2000 INDEX FUND | BNDW | 1,042,047 | $4,939,303 | 0.03% | Long | 2025-11-30 | |
| abrdn Life Sciences Investors | HQL | 1,021,063 | $4,564,152 | 0.81% | Long | 2026-03-31 | |
| Fidelity Series Growth Company Fund | — | 759,920 | $4,460,730 | 0.02% | Long | 2026-05-31 | |
| First Trust Small Cap Growth AlphaDEX Fund | — | 522,481 | $3,338,654 | 0.32% | Long | 2026-04-30 | |
| Fidelity Enhanced Small Cap ETF | FBCG | 601,616 | $3,308,888 | 0.10% | Long | 2025-12-31 | |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | BWX | 596,634 | $3,281,487 | 0.14% | Long | 2025-12-31 | |
| Fidelity Enhanced Small Cap ETF | — | 729,281 | $3,259,886 | 0.08% | Long | 2026-03-31 | |
| Schwab Small-Cap Index Fund | — | 482,940 | $3,085,987 | 0.04% | Long | 2026-04-30 | |
| iShares Micro-Cap ETF | AAXJ | 516,396 | $2,840,178 | 0.26% | Long | 2025-12-31 | |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | — | 598,759 | $2,676,453 | 0.11% | Long | 2026-03-31 | |
| iShares Micro-Cap ETF | — | 556,551 | $2,487,783 | 0.20% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 412,779 | $2,423,013 | 0.00% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 411,148 | $2,413,439 | 0.01% | Long | 2026-05-31 | |
| VANGUARD EXPLORER FUND | — | 374,723 | $2,394,480 | 0.01% | Long | 2026-04-30 | |
| Victory Small Cap Stock Fund | — | 358,021 | $2,287,754 | 0.25% | Long | 2026-04-30 | |
| Direxion Daily S&P Biotech Bull 3X Shares | — | 322,791 | $2,062,634 | 0.40% | Long | 2026-04-30 | |
| Fidelity Series Total Market Index Fund | — | 337,646 | $1,981,982 | 0.00% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE INDEX FUND | EDV | 413,625 | $1,960,583 | 0.01% | Long | 2025-11-30 | |
| VANGUARD U.S. MOMENTUM FACTOR ETF | — | 332,492 | $1,951,728 | 0.11% | Long | 2026-05-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | AAXJ | 310,159 | $1,705,875 | 0.00% | Long | 2025-12-31 | |
| ALPS Medical Breakthroughs ETF | — | 282,348 | $1,657,383 | 1.02% | Long | 2026-05-31 | |
| Invesco Dorsey Wright Healthcare Momentum ETF | CVY | 367,229 | $1,656,203 | 1.37% | Long | 2026-01-31 | |
| Nuveen Small Cap Blend Index Fund | — | 243,925 | $1,558,681 | 0.04% | Long | 2026-04-30 | |
| Master Small Cap Index Series | — | 340,182 | $1,520,614 | 0.03% | Long | 2026-03-31 | |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VFMF | 318,546 | $1,509,908 | 0.13% | Long | 2025-11-30 | |
| Nuveen Equity Index Fund | — | 228,660 | $1,461,137 | 0.00% | Long | 2026-04-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 321,904 | $1,438,911 | 0.00% | Long | 2026-03-31 | |
| Avantis U.S. Small Cap Equity ETF | ACSG | 264,130 | $1,251,976 | 0.06% | Long | 2025-11-30 |
Showing 1–50 of 217 positions
Key facts
CIK
1806310
CUSIP
877619106
13F (30d)
210 filings
204 filers
Visit website
Investor relations